You are here

Our science / Clinical Trials / Find a Trial / NCT01791855

PF-04634817 Renal Impairment Study

Back to Search Print Save as PDF Bookmark Trial

NCT01791855

Last updated on March 15, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Deland, Florida, 32720 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Renal Insufficiency
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female (non child bearing potential aged 18-75 years

- Documented renal impairment (mild, moderate or severe using Cockcroft-Gault equation)
or matched healthy volunteers (age, weight and gender)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with acute renal failure

- Subjects receiving, or likely to receive, CYP450 3A4 inhibitors

- Abnormal ECG at screening

NCT01791855
Pfizer
Completed
PF-04634817 Renal Impairment Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Renal Insufficiency
PF-04634817 Renal Impairment Study
NCT01791855
All Genders
18+
Years
Multiple Sites
End-Stage Renal Disease, Chronic Renal Insufficiency, Acute Renal Insufficiency
Bosutinib In Subjects With Renal Impairment
NCT01233882
All Genders
18+
Years
Multiple Sites
Chronic Renal Insufficiency
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
NCT00596518
All Genders
18+
Years
Multiple Sites
Renal Insufficiency, Pharmacokinetics
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
NCT00721422
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now